SHU Portfolio: 22nd Century Group Could Join The Ranks Of Big Tobacco
(WorldNews Health)

22nd Century Group (XXII) would be the big beneficiary of the FDA regulating nicotine to non-addictive levels in cigarettes as it has by far the best solution for that today. It also has several other market opportunities, which we will set out. We warn in advance though that this is part of the speculative corner with small companies in the SHU portfolio. As such, it only constitutes a small part of the SHU portfolio. The stock also remains very volatile, and timing of purchases isn`t straightforward. We originally liked the company years ago because it offered the combination of long-term lottery-type wins with nearer time expansion and break-even. The latter was supposed to be the product...